Four Treatment Cases of Psoriasis of Soyangins Demonstrated by Yang Poison Exanthema

Young-ho Weon; Weon, Young-ho

doi:10.13048/jkm.13021

JKM > Volume 34(3); 2013 > Article

Weon: Four Treatment Cases of Psoriasis of Soyangins Demonstrated by Yang Poison Exanthema

Case Report

Journal of Korean Medicine 2013; 34(3): 160-168.

Published online: September 30, 2013

DOI: https://doi.org/10.13048/jkm.13021

Four Treatment Cases of Psoriasis of Soyangins Demonstrated by Yang Poison Exanthema

Young-ho Weon

Haneul Maeum Oriental Medicine Clinic

Correspondence to: 원영호(Young-ho Weon), 서울 강동구 성내동 78-1번지 강동메디컬센타 4층 하늘마음한의원, Tel : +82-2-484-8075, Fax : +82-2-487-8229, E-mail: yhweon2@hanmail.net

Received June 28, 2013 Revised August 20, 2013 Accepted August 20, 2013

Abstract

Psoriasis is a chronic, recurrent skin disease without any cure so far. The symptoms of the guttate psoriasis of Soyangins going through tonsillitis and of the psoriasis under the steroid rebound phenomenon are identical to one of yang poison exanthema of a Soyangin. The study administered Yangdokbagho-tang, which is used to cure yang poison exanthema of Soyangins, and, as a result, showed significant treatment results from these two types of four clinical cases. Sasang medicine is considered an effective treatment method to cure psoriasis, an obstinate skin disease.

Keywords: Psoriasis, Yang poison exanthema, Yangdokbagho-tang, Soyangin

Fig. 1.

Before treatment in case 1(09/10/10)

Fig. 2.

After treatment in case 1(09/12/15)

Fig. 3.

Before treatment in case 2(12/10/19)

Fig. 4.

After treatment in case 2(12/12/08)

Fig. 5.

Before treatment in case 3(11/04/22)

Fig. 6.

After treatment in case 3(11/09/06)

Fig. 7.

Before treatment in case 4(12/07/09)

Fig. 8.

After treatment in case 4(12/10/22)

Table 1.

PASI Score Changes before and after Treatments in Case 1

	Before Treatment(2009.10.10) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals	After Treatment(2009.12.15) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals
Head	1×(3+1+1)×0.1=0.5	1×(0+0+0)×0.1=0
Trunk	1×(2+1+1)×0.3=1.2	1×(0+0+0)×0.3=0
Upper Limbs	2×(3+1+1)×0.2=2.0	1×(0+0+0)×0.2=0
Lower Limbs	2×(3+1+1)×0.4=4.0	1×(0+0+0)×0.4=0

PASI score	7.7	0

Table 2.

PASI Score Changes before and after Treatments in Case 2

	Before Treatment(2012.10.19) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals	After Treatment(2012.12.08) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals
Head	1×(2+1+1)×0.1=0.4	1×(0+0+0)×0.1=0
Trunk	1×(2+1+1)×0.3=1.2	1×(0+0+0)×0.3=0
Upper Limbs	2×(3+1+1)×0.2=2.0	1×(1+0+0)×0.2=0.2
Lower Limbs	2×(3+1+1)×0.4=4.0	1×(0+0+0)×0.4=0

PASI score	7.6	0.2

Table 3.

PASI Score Changes before and after Treatments in Case 3

	Before Treatment(2011.04.22) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals	After Treatment(2011.09.06) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals
Head	2×(4+1+2)×0.1=1.4	1×(0+0+0)×0.1=0
Trunk	2×(4+1+2)×0.3=4.2	1×(0+0+0)×0.3=0
Upper Limbs	4×(4+1+3)×0.2=6.4	1×(1+0+0)×0.2=0.2
Lower Limbs	3×(4+1+3)×0.4=9.6	1×(1+0+0)×0.4=0.4

PASI score	21.6	0.6

Table 4.

PASI Score Changes before and after Treatments in Case 4

	Before Treatment(2012.07.09) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals	After Treatment(2012.10.22) Surface area totals ×(Erythema+Thickness+Scaling)×Weighting Factor=Totals
Head	1×(2+1+1)×0.1=0.4	1×(0+0+0)×0.1=0
Trunk	2×(2+1+1)×0.3=2.4	1×(0+0+0)×0.3=0
Upper Limbs	3×(2+1+1)×0.2=2.4	1×(1+0+0)×0.2=0.2
Lower Limbs	3×(2+1+1)×0.4=4.8	1×(1+0+0)×0.4=0.4

PASI score	10.0	0.6

Reference

1.. The Korean Dermatological Association textbook complication committee complication. Dermatology. Seoul. Yeomungak;(1994). p. 123-36.

2.. Yoon JI. Psoriasis. Seoul. Korea medical book publisher;(1996). p. 15-27. p. 30-148.

3.. Jung JY, Han KH. Common skin diseases in Korea. Seoul. MD World;(2009). p. 168p. 176

4.. Kim, EY, Kim, KS, Lim, EC, Moon, SH, & KIM, KS. A Clinical Case Study of Chronic Psoriasis in Shaoyangin Patient. J Sasang Constitut Med, (2003). 15(2), 94-100.

5.. Lee, JH, Choi, JS, & Shin, MR. A Case Study of Psoriasis Treated with Soeumin Goepoong-san. J Sasang Constitut Med, (2012). 24(4), 92-99.

6.. Han, SJ, & Song, JM. Two Case of Psoriasis Treated with Sasang Constitutional Therapy and Fasting Therapy. J Sasang Constitut Med, (2010). 22(4), 130-139.

7.. Hong SY, Yie UH. Principles of Sasang medicine. Seoul. Haengrim;(1994). p. 134-6. p. 275-8. p. 301p. 325-6.

8.. Fredriksson, T, & Petterson, U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica, (1978). 157(4), 238-244.

9.. Chao YF. Zhubingyuanhoulun. Seoul. Jungdam Publishing Co;(1985). p. 796-8.

10.. Sanghai Chinese Medicine Private Educational Institute Book. The Orthopraxia of Chinese Medicine. Sanghai. Sangmuinseogwan;p. 141-145.

11.. Kim, NK, Hwang, CY, & Lim, GS. The Oriental and Occidental Bibliographic Study of Psoriasis. J Orient Med Surg Ophthalmol Otolaryngol, (1999). 12(1), 154-78.

12.. Oh, EY, Park, HS, Jee, SY, & Gu, DM. A Clinical Reports on Psoriasis. J Korean Orient Med Ophthalmol Otolaryngol Dermatol, (2001). 14(2), 278-85.

13.. A college of Korean medicine Association of Sasang medicine lecture room sewing. Sasang medicine. Seoul. Jipmoondang;(2012). p. 703